Sun Retreats From Alzheimer Drug Battle
Sun India Pharmaceuticals Inc. has backed off from marketing generic tablets of the lucrative Alzheimer's drug Namenda, becoming the latest manufacturer to surrender to Forest Laboratories Inc. in an ongoing patent...To view the full article, register now.
Already a subscriber? Click here to view full article